EuroSCORE II 在二尖瓣修复术中的可靠性:单中心验证研究
该单中心回顾性研究纳入2012至2019年2645例二尖瓣修复患者,评估EuroSCORE II对30天死亡的判别与校准能力。退行性二尖瓣反流患者中判别力低(AUC 0.68)、准确性低(Brier评分0.27)且校准差、高估死亡率;继发性二尖瓣反流患者中整体表现良好(AUC 0.88,Brier评分0.003)。
要点
- EuroSCORE II在退行性二尖瓣反流修复术中显著高估30天死亡率。
- 继发性二尖瓣反流患者中EuroSCORE II判别力与校准良好。
- 高流量中心二尖瓣修复经验丰富时EuroSCORE II准确性受限。
核心结论
- 在高流量且二尖瓣修复经验丰富的中心,EuroSCORE II对退行性二尖瓣反流手术患者显著高估30天死亡率。
研究设计与样本
- 单中心回顾性数据库分析,纳入2012年1月至2019年12月全部二尖瓣修复患者共2645例。
- 采用受试者工作特征曲线评估判别力,最大约登指数确定最佳截点。
- 通过校准图、Hosmer-Lemeshow拟合优度检验及Brier评分评估校准与准确性。
主要发现
- 总体中位EuroSCORE II为1.3%(0.6-2.0%)。
- 退行性二尖瓣反流患者中AUC为0.68,Brier评分为0.27,校准差且高估30天死亡率。
- 继发性二尖瓣反流患者中AUC为0.88,Brier评分为0.003,判别力、准确性与校准均良好。
关键数值与推荐
- 退行性二尖瓣反流:EuroSCORE II判别力低(AUC 0.68)、准确性低(Brier评分0.27)、校准差并高估死亡率。
- 继发性二尖瓣反流:EuroSCORE II判别力好(AUC 0.88)、准确性好(Brier评分0.003)、校准好。
临床怎么用
- 在高流量二尖瓣修复中心,对退行性二尖瓣反流患者不应仅凭EuroSCORE II评估手术风险。
- 继发性二尖瓣反流患者可参考EuroSCORE II进行30天死亡风险预测。
局限性
- 单中心回顾性设计,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The EuroSCORE II is widely used to predict 30-day mortality in patients undergoing open and transcatheter cardiac surgery. The aim of this study is to evaluate the discriminatory ability of the EuroSCORE II in predicting 30-day mortality in a large cohort of patients undergoing surgical mitral valve repair in a high-volume centre. METHODS: A retrospective review of our institutional database was carried on to find all patients who underwent mitral valve repair in our department from January 2012 to December 2019. Discrimination of the EuroSCORE II was assessed using receiver operating characteristic curves. The maximum Youden's Index was employed to define the optimal cut-point. Calibration was assessed by generating calibration plot that visually compares the predicted mortality with the observed mortality. Calibration was also tested with the Hosmer-Lemeshow goodness-of-fit test. Finally, the accuracy of the models was tested calculating the Brier score. RESULTS: A total of 2645 patients were identified, and the median EuroSCORE II was 1.3% (0.6-2.0%). In patients with degenerative mitral regurgitation (MR), the EuroSCORE II showed low discrimination (area under the curve 0.68), low accuracy (Brier score 0.27) and low calibration with overestimation of the 30-day mortality. In patients with secondary MR, the EuroSCORE II showed a good overall performance estimating the 30-day mortality with good discrimination (area under the curve 0.88), good accuracy (Brier score 0.003) and good calibration. CONCLUSIONS: In patients with degenerative MR operated on in a high-volume centre with a high level of expertise in mitral valve repair, the EuroSCORE II significantly overestimates the 30-day mortality.
引用
- Carino D, Denti P, Ascione G, et al. Is the EuroSCORE II reliable in surgical mitral valve repair? A single-centre validation study. Eur J Cardiothorac Surg. 2021. PMID: 33313790. doi:10.1093/ejcts/ezaa403
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。